Maynard Um
-
-
-
-
-
-
-
Dare Bioscience receives $3.6 million Gates Foundation grant payment
-
-
-
-
-
-
-
Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive
-
-
-
-
-
-
-
Dare Bioscience (DARE) Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder
-
-
-
-
-
-
-
Dare Bioscience (DARE) Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
-
-
-
-
-
400,253 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

